Apex Healthcare Bhd (XKLS:7090) Other Stockholders Equity: RM18.5 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7090 Apex Healthcare Bhd XKLS:7090
63 GF Score
Price RM2.61
GF Value RM2.27
! 8 Warning Signs
View Full Analysis

What is Apex Healthcare Bhd Other Stockholders Equity?

Apex Healthcare Bhd XKLS:7090 63 Other Stockholders Equity is RM18.5 Mil as of Sep. 2025. GuruFocus rates XKLS:7090 with a GF Score™ of 63/100 and a GF Value™ of RM2.27. The stock has 8 warning signs investors should review.

Apex Healthcare Bhd's Other Stockholders Equity for the quarter that ended in Sep. 2025 was RM18.5 Mil.

Apex Healthcare Bhd's quarterly Other Stockholders Equity increased from Mar. 2025 (RM18.8 Mil) to Jun. 2025 (RM18.9 Mil) but then declined from Jun. 2025 (RM18.9 Mil) to Sep. 2025 (RM18.5 Mil).

Apex Healthcare Bhd's annual Other Stockholders Equity increased from Dec. 2022 (RM19.8 Mil) to Dec. 2023 (RM22.5 Mil) but then declined from Dec. 2023 (RM22.5 Mil) to Dec. 2024 (RM18.6 Mil).

Apex Healthcare Bhd Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Apex Healthcare Bhd's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apex Healthcare Bhd Other Stockholders Equity Chart

Apex Healthcare Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.77 14.57 19.84 22.51 18.57

Apex Healthcare Bhd Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.46 18.57 18.78 18.90 18.52
XKLS:7090
63GF Score
Apex Healthcare Bhd XKLS:7090
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apex Healthcare Bhd Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of RM18.5 Mil mean?
Apex Healthcare Bhd (XKLS:7090) has a Other Stockholders Equity of RM18.5 Mil as of Sep. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Apex Healthcare Bhd and its competitors.
Is Apex Healthcare Bhd's Other Stockholders Equity too high?
Apex Healthcare Bhd's current Other Stockholders Equity is RM18.5 Mil. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's Other Stockholders Equity compare to MCK and COR?
Apex Healthcare Bhd's Other Stockholders Equity of RM18.5 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Distribution company?
A good Other Stockholders Equity depends on the Medical Distribution industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Apex Healthcare Bhd and its competitors. Apex Healthcare Bhd's current Other Stockholders Equity is RM18.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current Other Stockholders Equity of RM18.5 Mil. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current Other Stockholders Equity is RM18.5 Mil. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current Other Stockholders Equity is RM18.5 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?

Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued. The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.

Key valuation signals for XKLS:7090:

  • Other Stockholders Equity: RM18.5 Mil
  • GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apex Healthcare Bhd Business Description

Address 1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score

Get the complete analysis for XKLS:7090

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.61
Price
RM2.27
GF Value